Deal of the Day — limited-time pharmacy picks!
Novorapid Penfill 100 IU Inj 3 ml Cartridge

Novorapid Penfill 100 IU Inj 3 ml Cartridge

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Insulin Aspart (100IU/ml)

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

5 Cartridge

About The Product

Fast-acting insulin for meal-time sugar control

Novorapid Penfill 100 IU Inj 3 ml Cartridge is a prescription based medicine with Insulin Aspart (100IU/ml) as an active ingredient. It is used to treat type 1 and type 2 diabetes mellitus by improving blood sugar control.

Humalog Lispro is a fast-acting type of insulin which helps to minimize the blood sugar levels after meals and also decrease the chances of developing serious complications of diabetes. It is commonly prescribed along with a long-acting type of insulin or other diabetes medicines.


Uses

Type 1 and Type 2 diabetes mellitus


Side Effects

Like any other medicine, Novorapid Penfill 100 IU Inj 3 ml Cartridge also has some common to severe side effects. These undesired symptoms observed in the body after taking this injection and usually disappear with time as the body adjusts to the medicine.

Common Side Effects Include:

  • Infusion site reaction
  • Headache
  • Pain
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Auto-antibody formation
  • Allergic reaction
  • Injection site reactions (pain, swelling, redness)
  • Weight gain
  • Hypoglycemia (low blood glucose level)

However, if the symptoms don't disappear with time or you have severe side effects, then consult your doctor immediately.

How To Use

  • Dosage of this injection determined by the doctor as per the type of disease and overall health condition of the patient.
  • Correct way of injecting Novorapid Penfill 100 IU Inj 3 ml under the skin teach by your healthcare provider.
  • It should be taken 15 minutes before a meal or within 20 minutes after starting a meal.
  • Do not stop the medication without doctor's advice.

How It Works

Novorapid Penfill 100 IU Inj 3 ml Cartridge is a fast-acting insulin with Insulin Aspart (100IU/ml) as an active ingredient. It starts working within 10-20 minutes after injecting.

This injection acts similarly as like the insulin produced by the body. Insulin facilitates reuptake of glucose in muscle and fat cells and also blocks the release of glucose from the liver.

Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Novorapid Penfill 100 IU Inj 3 ml, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.
Pregnancy
Novorapid Penfill 100 IU Inj 3 ml is safe to use during pregnancy, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
Breast Feeding
Novorapid Penfill 100 IU Inj 3 ml is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
Driving
Novorapid Penfill 100 IU Inj 3 ml Cartridge may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
Kidney
Share your medical history with the doctor before starting the Novorapid Penfill 100 IU Inj 3 ml. Do not take it without consulting a doctor if you have any kidney related issue.Share your medical history with the doctor before starting the Novorapid Penfill 100 IU Inj 3 ml. Do not take it without consulting a doctor if you have any kidney related issue.
Liver
Share your medical history with the doctor before starting the Novorapid Penfill 100 IU Inj 3 ml. Do not take it without consulting a doctor if you have any liver related issue.

FAQs

Novorapid Penfill 100 IU Inj 3 ml is a fast-acting insulin that used to treat type 1 and type 2 diabetes mellitus by improving blood sugar control.


References

  • Nosrati, M., Ahmadi Fariman, S., Saiyarsarai, P., & Nikfar, S. (2023). Pharmacoeconomic evaluation of insulin aspart and glargine in type 1 and 2 diabetes mellitus in Iran. Journal of Diabetes & Metabolic Disorders, 22(1), 817-825.
  • Zargar, A. A., Kumar, R., Kumar, A., Gangwar, R., & Sharma, A. (2024). Centenary of Insulin Therapy: A Review. Current Diabetes Reviews, 20(1), 6-18.Song, D., & Davidson, J. (2007). Cross-reactivity of Actrapid and three insulin analogues in the Abbott IMx insulin immunoassay. Annals of clinical biochemistry, 44(2), 197-198.
  • Danne, T., Bangstad, H. J., Deeb, L., Jarosz‐Chobot, P., Mungaie, L., Saboo, B., ... & Hanas, R. (2014). Insulin treatment in children and adolescents with diabetes. Pediatric diabetes, 15.
  • Dutta, D., Mohindra, R., Mahajan, K., & Sharma, M. (2023). Performance of fast-acting aspart insulin as compared to aspart insulin in insulin pump for managing type 1 diabetes mellitus: a meta-analysis. Diabetes & Metabolism Journal, 47(1), 72-81.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026